LoginSignup
Imagen de perfil
BamBamInvest
@BamBamInvest
1D¡

Valuation Healthcare sector - Goldman Sachs

Imagen de perfil
BamBamInvest
@BamBamInvest
1D¡

Weak US healthcare sector

$UNH (+0,58 %)
$OSCR
$XDWH (+0,76 %)
$ELV (+0,23 %)
$LLY (+1,26 %)
$XLV (+0,94 %)


The US healthcare sector is experiencing its biggest crash in the last 20 years.


If the strong weighting no. 1 $LLY (+1,26 %) (over 12%), one would have to go back even further/longer. (probably before the existence of the ETF).


I have positioned myself strongly here as I believe this is a great opportunity.


I also believe that a lot of capital will flow into the sector in the coming months. ✌️


Do you have a similar view? ✌️

attachment
9
5 Comentarios
Imagen de perfil
Tenbagger2024@Tenbagger2024
1D
I still have one US pharma share on my buy list.
But I'm wondering whether I should get in before August.
•
2
•
Imagen de perfil
BamBamInvest@BamBamInvest
1D
@Tenbagger2024 I don't think anyone can answer that 😁. I think the healthcare sector for diversification is certainly not a mistake at the moment.
•
1
•
Imagen de perfil
Michey777@Michey777
20H
@Tenbagger2024 would expect a rotation from August. Tariffs on everything will be higher than expected, pharma will remain exempt as Trump cannot afford this. The requirement to produce in the USA in 1-2 years is still a long way off (current requirement) and many are already producing there (not counting preliminary products).
•
1
•
Imagen de perfil
Michey777@Michey777
20H
If you define yourself as a long-term investor, you can definitely bag favorable entry prices here! The revaluation will come, especially when momentum is lower. So far I have bought $TMO $MRK $AZN. I think we will see more inflows here again from August.
•
1
•
Imagen de perfil
BamBamInvest@BamBamInvest
20H
@Michey777 I see it the same way 👌
•
1
•
Únase a la conversación
InscrĂ­baseInicio de sesiĂłn